Healthcare Business

By AMI PAREKH A little-noticed telehealth safe harbor provision tucked inside the One Big Beautiful Bill was a significant milestone in virtual care....

Employers across the US continue to view health care affordability as their most pressing benefits challenge, with drug prices, hospital prices, and h...

Living with multiple sclerosis (MS) can be a journey of uncertainty, marked by unpredictable neurological symptoms and the gradual progression of disa...

Patients with psoriasis increasingly turn to digital media for information, support, and alternative therapies, but many encounter misinformation and...

Recognition and testing for ROS1 rearrangements in non-small cell lung cancer (NSCLC) have significantly advanced in recent years. Initially, ROS1 was...

Janus kinase 1 (JAK1) inhibitors showed potential superior efficacy vs anti–IL-13 antibodies among 75 patients receiving treatment for moderate to sev...

ABSTRACT Objectives: To understand the perceptions of patients and primary care physicians as well as barriers to and facilitators of engaging with a...

The treatment of non–small cell lung cancer (NSCLC) harboring EGFR mutations has transformed with the introduction of targeted therapies. Despite the...

Today, the FDA approved selumetinib (Koselugo; AstraZeneca) in both granule and capsule forms for pediatric patients as young as 1 year old with neuro...

Durable and significant improvements in survival outcomes were seen at 5 years of follow-up among patients with non-small cell lung cancer (NSCLC) usi...